GlassScriptPhysician profile
Marna List
NPI 1962073270
$2,096.83
in general payments reported to CMS, 2019-2025
11 companies · $973 in 2025
The $973 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $307 · 2024: $567 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,540.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $731.85 | 2024-2025 | Trumatch |
| Inspire Medical Systems, INC. | $503.65 | 2024-2025 | Inspire |
| Medtronic, INC. | $320.67 | 2022-2024 | Stealthstation S8 Platform, Propel |
| Glaxosmithkline, LLC. | $250.00 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2021 | |
| Axogen | $71.97 | 2025 | |
| Boston Scientific Corporation | $23.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.02 | 2025 | |
| Tempus Ai, INC | $21.31 | 2024 | Xt Cdx |
| Olympus America INC. | $13.47 | 2024 | Connecting Tube, Rhino-Laryngo Videoscope |
| Ormco Corporation | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marna List listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.